1-55056233-A-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_174936.4(PCSK9):c.996+44A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.038 ( 0 hom., cov: 0)
Exomes 𝑓: 0.0088 ( 2 hom. )
Failed GnomAD Quality Control
Consequence
PCSK9
NM_174936.4 intron
NM_174936.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.84
Publications
0 publications found
Genes affected
PCSK9 (HGNC:20001): (proprotein convertase subtilisin/kexin type 9) This gene encodes a member of the subtilisin-like proprotein convertase family, which includes proteases that process protein and peptide precursors trafficking through regulated or constitutive branches of the secretory pathway. The encoded protein undergoes an autocatalytic processing event with its prosegment in the ER and is constitutively secreted as an inactive protease into the extracellular matrix and trans-Golgi network. It is expressed in liver, intestine and kidney tissues and escorts specific receptors for lysosomal degradation. It plays a role in cholesterol and fatty acid metabolism. Mutations in this gene have been associated with autosomal dominant familial hypercholesterolemia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2014]
PCSK9 Gene-Disease associations (from GenCC):
- hypercholesterolemia, autosomal dominant, 3Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- homozygous familial hypercholesterolemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 1-55056233-A-T is Benign according to our data. Variant chr1-55056233-A-T is described in ClinVar as Benign. ClinVar VariationId is 1711218.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.216 is higher than 0.05.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_174936.4. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
Frequencies
GnomAD3 genomes AF: 0.0376 AC: 93AN: 2474Hom.: 0 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
93
AN:
2474
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000241 AC: 2AN: 8282 AF XY: 0.000248 show subpopulations
GnomAD2 exomes
AF:
AC:
2
AN:
8282
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00877 AC: 376AN: 42874Hom.: 2 Cov.: 0 AF XY: 0.00906 AC XY: 182AN XY: 20088 show subpopulations
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
376
AN:
42874
Hom.:
Cov.:
0
AF XY:
AC XY:
182
AN XY:
20088
show subpopulations
African (AFR)
AF:
AC:
5
AN:
2172
American (AMR)
AF:
AC:
6
AN:
124
Ashkenazi Jewish (ASJ)
AF:
AC:
146
AN:
568
East Asian (EAS)
AF:
AC:
0
AN:
424
South Asian (SAS)
AF:
AC:
0
AN:
1912
European-Finnish (FIN)
AF:
AC:
0
AN:
396
Middle Eastern (MID)
AF:
AC:
7
AN:
122
European-Non Finnish (NFE)
AF:
AC:
165
AN:
35438
Other (OTH)
AF:
AC:
47
AN:
1718
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.672
Heterozygous variant carriers
0
15
30
44
59
74
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0376 AC: 93AN: 2476Hom.: 0 Cov.: 0 AF XY: 0.0325 AC XY: 38AN XY: 1170 show subpopulations
GnomAD4 genome
AF:
AC:
93
AN:
2476
Hom.:
Cov.:
0
AF XY:
AC XY:
38
AN XY:
1170
show subpopulations
African (AFR)
AF:
AC:
4
AN:
2078
American (AMR)
AF:
AC:
11
AN:
98
Ashkenazi Jewish (ASJ)
AF:
AC:
34
AN:
74
East Asian (EAS)
AF:
AC:
0
AN:
38
South Asian (SAS)
AF:
AC:
0
AN:
10
European-Finnish (FIN)
AF:
AC:
0
AN:
16
Middle Eastern (MID)
AF:
AC:
1
AN:
4
European-Non Finnish (NFE)
AF:
AC:
37
AN:
128
Other (OTH)
AF:
AC:
6
AN:
30
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
4
8
11
15
19
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
ClinVar submissions
View on ClinVar Significance:Benign
Revision:criteria provided, single submitter
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.